Tenax Therapeutics (TENX) Times Interest Earned (2010 - 2026)
Tenax Therapeutics (TENX) posted quarterly Times Interest Earned of -$0.32 for Q2 2026, up 99.99% year-over-year from -$0.16 in Q2 2025, and down 35.23% on a QoQ basis from -$0.24 in Q1 2026.
Tenax Therapeutics (TENX) Times Interest Earned (2010 - 2026) Analysis & Trends
Tenax Therapeutics has reported Times Interest Earned for 15 years, with the latest figure at -$0.32 in Q2 2026.
- Times Interest Earned for Q2 2026 came in at -$0.32, up 99.99% year-over-year; the trailing twelve-month figure through Jun 2026 was -$1.17 (up 99.99% YoY), and the FY2025 annual result was -$1.12, down 139.4% from the prior year.
- Times Interest Earned eased to -$0.32 in Q2 2026, from -$0.24 in the prior quarter.
- Over five years, Times Interest Earned peaked at $7295.0 in Q4 2024 and troughed at -$6002.3 in Q4 2023.
- A 5-year average of -$744.55 and a median of -$0.92 in 2025 frame the typical range for Times Interest Earned.
- The widest annual swing landed in 2023, when Times Interest Earned soared 926.43%; it then tumbled 1345.49% in 2025.
- A 5-year view of Times Interest Earned shows it stood at $12.82 in 2022, then tumbled by 46914.13% to -$6002.3 in 2023, then soared by 221.54% to $7295.0 in 2024, then slumped by 100.02% to -$1.53 in 2025, then jumped by 79.02% to -$0.32 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.32 in Q2 2026, -$0.24 in Q1 2026, and -$1.53 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.32 |
| Mar 31, 2026 | -0.24 |
| Sep 30, 2025 | -1.53 |
| Jun 30, 2025 | -5,896.00 |
| Mar 31, 2025 | -5,939.24 |
| Sep 30, 2024 | -659.86 |
| Jun 30, 2024 | -407.89 |
| Mar 31, 2024 | -488.63 |
| Dec 31, 2023 | -4,607.58 |
| Sep 30, 2023 | 131.60 |
| Jun 30, 2023 | 68.23 |
| Mar 31, 2023 | -44.78 |
| Sep 30, 2022 | 12.82 |
| Jun 30, 2022 | 11.02 |
| Mar 31, 2022 | 9.35 |
| Sep 30, 2021 | 10.76 |
| Jun 30, 2021 | 15.52 |
| Mar 31, 2021 | 762.33 |
| Dec 31, 2020 | 1,071.99 |
| Sep 30, 2020 | 24.13 |